Published in Cell Prolif on June 06, 2011
Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab (2014) 2.35
Biomimetic, synthetic HDL nanostructures for lymphoma. Proc Natl Acad Sci U S A (2013) 1.13
Acyl-CoA:cholesterol acyltransferases (ACATs/SOATs): Enzymes with multiple sterols as substrates and as activators. J Steroid Biochem Mol Biol (2014) 0.88
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration. Front Physiol (2013) 0.84
Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer. Oncogene (2016) 0.83
2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent. PLoS One (2015) 0.76
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia. Oncotarget (2017) 0.75
Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia. PLoS One (2017) 0.75
Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med (1994) 1.84
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol (2000) 1.59
A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology (1992) 1.52
Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature (1979) 1.51
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol (2006) 1.47
Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artifactual production of procapsids. J Virol (1981) 1.31
Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Interact (1984) 1.26
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC). Br J Cancer (2005) 1.18
Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology (1993) 1.11
Pyrazole-related nucleosides. Synthesis and antiviral/antitumor activity of some substituted pyrazole and pyrazolo[4,3-d]-1,2,3-triazin-4-one nucleosides. J Med Chem (1992) 1.06
Rapid and sensitive determination of urinary 2,5-hexanedione by reversed-phase high-performance liquid chromatography. J Chromatogr (1992) 1.05
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis (1999) 1.04
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Lung Cancer (2001) 1.02
Survey on the prevalence of leptospira infections in the Italian population. Eur J Epidemiol (1994) 1.01
Altered pattern of lipid metabolism in patients with lung cancer. Oncology (1992) 0.98
Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol (1986) 0.97
Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer. Eur J Histochem (2011) 0.94
Elevated plasma levels of beta-thromboglobulin in breast cancer. Oncology (1986) 0.91
Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol (1991) 0.90
Synthesis and antimicrobial activity of new 3-(1-R-3(5)-methyl-4-nitroso-1H-5(3)-pyrazolyl)-5-methylisoxazoles. Bioorg Med Chem (2000) 0.89
Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group. J Clin Oncol (1999) 0.88
Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated? Clin Infect Dis (2001) 0.88
Variations of serum lipoproteins during cell proliferation induced by lead nitrate. Exp Mol Pathol (1989) 0.87
A kinase able to phosphorylate exogenous protein synthesis initiation factor eIF-2 alpha is present in lysates of mengovirus-infected L cells. J Virol (1986) 0.87
Serum lipoprotein pattern as modified in G6PD-deficient children during haemolytic anaemia induced by fava bean ingestion. Int J Exp Pathol (1992) 0.86
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
Nasal bleeding associated with fluoxetine and risperidone interaction: a case report. Pharmacopsychiatry (2009) 0.85
Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial. J Nephrol (2000) 0.84
G6PD activity and gene expression in leukemic cells from G6PD-deficient subjects. Cancer Lett (1999) 0.84
Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells. Cell Prolif (2002) 0.83
Local transcription of complement C3 in human allograft rejection. Evidence for a pathogenic role and correlation to histology and outcome. Transplantation (1994) 0.83
Structure-activity relationship studies on new DABOS: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity. Antivir Chem Chemother (2001) 0.83
High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment. J Endocrinol Invest (1999) 0.83
Pyrazole-related nucleosides. 4. Synthesis and antitumor activity of some 1-tetrahydropyranyl-4-substituted pyrazoles. Anticancer Drug Des (1996) 0.82
Characterization and role in morphogenesis of a new subviral particle (55S) isolated from poliovirus-infected cells. J Virol (1987) 0.82
[Current trends in the treatment of Graves' disease]. Minerva Chir (1996) 0.82
A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer. Anticancer Res (2002) 0.82
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: long term results of the Italian Tamoxifen Anastrozole trial. Eur J Cancer (2013) 0.82
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients. Br J Cancer (2004) 0.82
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients. Cancer Chemother Pharmacol (1999) 0.81
MDR1 gene expression in normal and atherosclerotic human arteries(1). J Vasc Res (1999) 0.81
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition. J Med Chem (1999) 0.81
MDR1, cholesterol certification and cell growth: a comparative study in normal and multidrug-resistant KB cell lines. Cell Mol Life Sci (2000) 0.81
Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study. Cancer Chemother Pharmacol (2005) 0.81
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study. Oncology (2005) 0.81
Lipid metabolism and molecular changes in normal and atherosclerotic vessels. Eur J Vasc Endovasc Surg (2001) 0.80
Hexose monophosphate shunt and cholesterol synthesis in the diabetic and fasting states. Exp Mol Pathol (1985) 0.80
Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules. Carcinogenesis (1985) 0.80
Serum lipoproteins during bone marrow hyperplasia after phenylhydrazine administration in rats. Int J Exp Pathol (1990) 0.80
Differential effects of choline administration on liver microsomes of female and male rats. Exp Mol Pathol (1978) 0.80
Variation in resistance of cells from inbred strains of mice to herpes simplex virus type 1. J Gen Virol (1983) 0.79
Preservative systems containing essential oils in cosmetic products. Int J Cosmet Sci (2002) 0.79
Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study. Cancer Treat Rep (1981) 0.79
Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma? J Chemother (1995) 0.79
[Estrogen therapy of advanced breast cancer]. Minerva Med (1977) 0.79
Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells. Cell Mol Life Sci (2001) 0.79
Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines. Cell Prolif (1999) 0.79
Doxorubicin-docetaxel sequential schedule: results of front-line treatment in advanced breast cancer. Oncology (2002) 0.78
Antiviral activity of glycyrrhizic acid. Experientia (1980) 0.78
Vegan-vegetarian diets in pregnancy: danger or panacea? A systematic narrative review. BJOG (2015) 0.78
Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine with potent antitumor and antimicrobial activity. J Med Chem (1999) 0.78
Determination of bezafibrate concentration by high performance liquid-chromatography in serum of rats treated with lead nitrate. Farmaco (1999) 0.77
Effects of antiestrogen and progestin on immune functions in breast cancer patients. Cancer (1988) 0.77
[Clinical guidelines for the management of gastrointestinal stromal tumors]. Clin Ter (2006) 0.77
Influence of lead nitrate on dimethylnitrosamine intoxication. Chem Biol Interact (1976) 0.77
Intra- and intercellular distribution of mitochondrial probes and changes after treatment with MDR modulators. IUBMB Life (2001) 0.77
Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulin. J Nutr (1999) 0.76
Acute renal failure after massive ingestion of gliclazide in a suicide attempt. Ren Fail (1998) 0.76
Cancer patients as 'experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO). Qual Life Res (2000) 0.76
Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study. Eur J Epidemiol (1992) 0.76
Results in treatment of distal femur fractures using polyaxial locking plate. Strategies Trauma Limb Reconstr (2013) 0.76
Effect of i.v. indoprofen on cancer pain and serum prolactin and growth hormone levels--a controlled pharmacologic study vs i. m. morphine and placebo. Int J Clin Pharmacol Ther Toxicol (1983) 0.75
Effect of 3-MC on cholesterolemia and hepatic G-6-PD. Res Commun Chem Pathol Pharmacol (1983) 0.75
Mediterranean spotted fever with acute renal failure stimulating a relapse in C-ANCA vasculitis. Nephron (1998) 0.75
[Progress in the diagnosis of unknown primary neoplasms]. Minerva Chir (1990) 0.75
[Therapeutic strategy in Basedow's disease. Role of surgery]. Minerva Chir (1989) 0.75
[Action of topical metronidazole on hypertrichosis]. Atti Accad Med Lomb (1973) 0.75
[Treatment of trichocephaliasis with N-(2'-chlor-4'-nitrophenyl)-5-chlorsalicylamide]. Clin Ter (1970) 0.75
[Carcinoma of the male breast. Review of the literature and case series contribution]. Minerva Chir (1990) 0.75
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial. Tumori (2000) 0.75
[Current aspects of precautional therapy of colorectal neoplasms]. Minerva Med (1980) 0.75
[Polychemotherapy of advanced cancer of the breast]. Minerva Med (1978) 0.75
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study. Anticancer Res (2007) 0.75
Histopathological study of a case of systemic angiofollicular hyperplasia (Castleman's disease). Pathologica (1990) 0.75
[Acute abdomen in patients with hematologic neoplasms]. Minerva Chir (1990) 0.75
[Paraneoplastic hypercorticism syndrome]. G Clin Med (1969) 0.75
Randomised controlled trial evaluating the role of tirofiban in high-risk non-ST elevation acute coronary syndromes: an East Indian perspective. Singapore Med J (2010) 0.75
Neoadjuvant chemotherapy with cisplatinum and 5-fluorouracil in advanced head and neck cancer. J Chemother (1990) 0.75
[Changes of some plasmatic and urinary indexes in atherosclerosis patients treated with HCG]. Minerva Med (1971) 0.75
[Anabolizing steroids associated with insulin-glucose in the therapy of hyperazotemic states]. Clin Ter (1968) 0.75
[Hormonal therapy with androgenic steroids in diffuse malignant neoplasms of the breast]. Minerva Med (1977) 0.75